Alterome Therapeutics Welcomes Andrew S. Chi, M.D., Ph.D., as Chief Medical Officer - Alterome

About
Overview Leadership The A-team BOD Advisors Investors Contact
Science
Approach AKT-driven cancers KRAS-driven cancers
Pipeline
Overview Tanerasertib (ALTA2618): AKT1 E17K ALTA3263: KRAS
News
Careers
Overview Mission & values Benefits Open positions Corporate responsibility

Alterome Therapeutics Welcomes Andrew S. Chi, M.D., Ph.D., as Chief Medical Officer

Contact us

Alterome Therapeutics
13480 Evening Creek Drive North
Suite 450
San Diego, CA 92128

General information
info@alterome.com

Clinical trials
clinical.trials@alterome.com

Privacy Policy Terms of Use

© 2026 Alterome Therapeutics.
All rights reserved.